Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What CAGR Is Anticipated for the Dry Eye Syndrome Market Through 2029?

In recent times, the dry eye syndrome market has seen a marked growth in its size. The market, which is projected to increase from $3.92 billion in 2024 to $4.17 billion in 2025, is expected to experience a compound annual growth rate (CAGR) of 6.3%. Factors like the availability of healthcare, advancement in treatment options, medication and health conditions, hormonal adjustments, as well as the effect of ocular surgery have contributed to this growth during the historic period.

The market size for dry eye syndrome is projected to witness solid expansion in the coming years. The sector is set to inflate to $5.51 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.2%. The surge during the forecasted timeframe can be credited to factors such as a growing elderly population, increased use of screens, changes in lifestyle patterns, accessibility and awareness of healthcare, ocular surgery trends and introduction of innovative therapies. Key trends for this forecast period consist of a comprehensive approach to eye health, the use of artificial intelligence in eye care, telemedicine and remote consultations, personalized treatment methods, and the growth of awareness and education.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10704&type=smp

What Market Forces Are Driving The Dry Eye Syndrome Sector In 2025 And Beyond?

The dry eye syndrome market is predicted to expand due to the increasing instances of dry eye syndrome. This condition refers to the inadequate production of tears by the eyes. A variety of products and medications are available to manage this ailment by enhancing tear generation, improving tear quality, reducing inflammation, and safeguarding the ocular surface. A recent study in March 2022, conducted by Eyes On Eyecare involving 540 eyecare specialists revealed that approximately 35 million Americans are projected to be affected by dry eye disease (DED) in 2022, and this number is steadily increasing. In addition, a 2022 meta-analysis of three US studies by UpToDate Inc., a health information provider, revealed a pooled prevalence rate of dry eye syndrome to be 8.1%. Therefore, the increasing instances of dry eye syndrome are prompting the expansion of the dry eye syndrome market.

How Is The Global Dry Eye Syndrome Market Categorized By Segments?

The dry eye syndrome market covered in this report is segmented –

1) By Product: Liquid Drops, Gel, Liquid Wipes, Eye Ointment, Other Products

2) By Treatment: Corticosteroids, Artificial Tears, Oral Omega Supplements, Lubricating Agent, Other Treatments

3) By Disease Type: Evaporative, Aqueous

4) By Distribution Channel: Offline, Online

5) By Application: Hospitals And Clinics, Medical Laboratories, Other Applications

Subsegments:

1) By Liquid Drops: Preservative-Free Drops, Preserved Liquid Drops, Antibiotic-Infused Drops

2) By Gel: Long-Lasting Gels, Hydrogel Formulations

3) By Liquid Wipes: Pre-Moistened Wipes, Anti-Bacterial Wipes

4) By Eye Ointment: Night-Time Ointments, Therapeutic Ointments

5) By Other Products: Eye Masks, Contact Lens Solutions, Nutritional Supplements

What Long-Term Trends Are Likely To Affect The Dry Eye Syndrome Market?

A significant trend gaining traction in the dry eye syndrome market is product innovation. Leading companies in the dry eye syndrome home care segment are creating unique products to maintain their market stronghold. For example, in May 2023, India’s Entod Pharmaceuticals Ltd. Introduced Cyclotears eye drops, designed specifically for dry eye afflictions. These revolutionary drops employ the use of a self-emulsifying drug delivery system (SEDDS) technology, heightening the ocular delivery of treatments that are poorly soluble in water. Cyclotears is formulated with the innovatively utilized cyclodextrin, aimed to augment the stability and longevity of the tear film on the eye’s surface. Claimed advantages of Cyclotears eye drops feature a unique active constituent, extended retention period, lubricatory enhancement, and safety owing to its preservative-free nature.

Which Firms Are Considered Leaders In The Dry Eye Syndrome Market Space?

Major companies operating in the dry eye syndrome market include Allergan plc, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Santendo Pharmaceutical Co. Ltd., Sentiss Pharma Pvt. Ltd., Johnson & Johnson, Alcon Vision LLC, Akorn Operating Company LLC, Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., AbbVie Inc., I-MED Pharma Inc., AFT Pharmaceuticals, Horus Pharma, Mitotech, Novaliq GmbH, OASIS Medical, Prestige Consumer Healthcare, VISUfarma, Alimera Science, Kala Pharmaceuticals Inc., Nicox S.A., EyeGate Pharmaceuticals Inc., ReVision Therapeutics Inc., Itear Medical

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/dry-eye-syndrome-global-market-report

What Role Do Regional Policies And Investments Play In Dry Eye Syndrome Market Expansion?

North America was the largest region in the dry eye syndrome market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global dry eye syndrome market report during the forecast period. The regions covered in the dry eye syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10704&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model